Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

Every life sciences company knows that patient safety is non negotiable, but the way safety is managed—and the value ...

Boeing subsidiary Aurora Flight Sciences has completed fuselage fabrication for the X-65, an experimental aircraft that ...

The Triangle’s life sciences sector is in the midst of one of the most significant growth waves in its history. But as the ...

Q4 2025 earnings call recap: 2026 revenue guidance, TearCare reimbursement milestone, OMNI growth outlook, margins and risks—read now.

Q4 2025 earnings call recap: 60% revenue growth, 2026 guidance of $60–$62M, PEDD/TriNav expansion, funding and risks—read now.

AICA currently supports auditing against 21 CFR Parts 11, 211, and 600, each mapped at the section and subsection levels.

Gilead Sciences has agreed to buy the rest of development partner Arcellx in a deal that values the biotechnology company at about $7.8 billion at closing.

Following a difficult start in 2025, the ever-evolving life sciences segment recovered strongly in the latter half of the year.

The Penn Museum and the Academy of Natural Sciences of Drexel University have discontinued their long-running summer camp ...